For example, MMP2 supplementation has been shown to ameliorate drusen accumulation, while MMP9 and APP have been identified as potential AMD biomarkers (Lynn et al., 2022; Hussain et al., 2011). The gene discussed is APP; the disease is age-related macular degeneration.